Health
Personalized mRNA Vaccine Shows Promise
A personalized mRNA vaccine developed by Moderna and Merck has shown promise in reducing the recurrence of melanoma, a deadly form of skin cancer. The findings were released after tracking the impact of the vaccine for five years.
Coverage timeline — 1 article
The Hill
Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown promise in reducing the return of melanoma, the deadliest form of skin cancer. The findings were unearthed by researchers who tracked the impact of the vaccine five years after ind
2026-06-01 16:59 UTC